Health Care Practice Group Co-Leader Douglas Grimm and Counsel Susanna Hathaway Murphy were recently quoted in an International Business Times article. The article addresses the Coronavirus aftermath and the related impact on the economy and the health care industry.
International Co-Leader and Litigation Partner Malcolm McNeil participated in a 3 part online series on coronavirus-related business and legal developments hosted by the Beverly Hills Bar Association.
Partner Joel Wallace shared his insight on the updated guidelines from the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) on running clinical trials and the potential effects of the COVID-19 pandemic on those trials.   
Partner Steven Wilamowsky was quoted on how potential culture shifts stemming from the COVID-19 pandemic directives on social distancing could affect private sectors like private education.
In response to the COVID-19 pandemic, we want to provide you with an update on our ongoing efforts to continue assisting clients while also protecting the health and safety of our workforce.
Bloomberg Environment
E&E News Greenwire
In March 2020, Health Care Partner Anne Murphy published an article in AHLA Weekly on compliance considerations when closing a hospital.
In March 2020, FDA Associate Emily Leongini was quoted in Hemp Industry Daily regarding statements made by the Commissioner of the US Food and Drug Administration, Dr. Stephen Hahn regarding CBD.
Arent Fox Partner Jim Davis was recently quoted in a World Trademark Review article titled “How the SHOP SAFE Act might change the ecommerce counterfeiting liability landscape.”
AF International Co-Leader and Litigation Partner Malcolm McNeil was recently quoted in Marijuana Business Magazine in an article titled “Cash Cow”. The article addresses the current trend of large multistate marijuana companies wanting to turn their real estate into quick cash, providing a valuable